Morphosys AG - ADR (MOR) Company Profile & Statistics

Morphosys AG - ADR
MOR
(Nasdaq - US)
N/A
19.39
+0.89 (+4.81%)
in:usd•As of: May 16, 2024 15:59 UTC -4
Pre Market:18.91-0.48 (-2.48%)
Open
18.87
High
19.50
Low
18.82

About Morphosys AG - ADR

CEO

Jean-Paul Kress

Headquarters

semmelweisstr. 7

planegg, 2m 82152, germany

Auditor

PricewaterhouseCoopers GmbH

Employees

524

Share Holders

N/A

Website

www.morphosys.com

Industry

biotechnology

Sector

health technology

Company Overview

MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company's proprietary portfolio consists of MOR208, MOR202, MOR103, MOR106 and MOR107. Its partnered programs lighthouse project includes Tremfya(R) and Gantenerumab. MorphoSys AG is based in Planegg, Germany.

Morphosys AG - ADR Statistics

Valuation Measures

Market Capitalization ²	2.92B
Enterprise Value	3.01B
Enterprise Value/EBITDA (ttm)	-11.51
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	12.55
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	75.83%
Operating Margin (ttm)	-224.87%
Profit Margin (ttm)	-78.59%
Return on Equity (ttm)	-694.31%
Return on Invested Capital (ttm)	-92.05%
Return on Assets (ttm)	-22.55%

Income Statement

Revenue (ttm)	257.89M
Revenue Per Share (ttm)	1.71
Gross Profit (ttm)	194.73M
EBITDA (ttm)³	-261.85M
Net Income Avi to Common (ttm)	-205.35M
Diluted EPS (ttm)	-3.48

Share Statistics

Beta (5Y Monthly)	1.15
52-Week Change	225.88%
S&P500 52-Week Change	27.37%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	150.62M
Dividend Yield	0.00%
Float ⁴	150.55M
% Held by Insiders	0.05%
% Held by Institutions	18.38%

Balance Sheet

Total Cash (mrq)	738.95M
Total Cash Per Share (mrq)	4.91
Total Debt (mrq)	265.88M
Total Debt/Equity (mrq)	500.84%
Current Ratio (mrq)	3.08%
Quick Ratio (mrq)	1.38%
Book Value Per Share (mrq)	0.35

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.33
Free Cash Flow (ytd)	-320.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Morphosys AG - ADR

Trade With A Regulated Broker